Recalls / Active ingredient / Naltrexone Hydrochloride
Naltrexone Hydrochloride
3 FDA drug recalls involving the active ingredient “Naltrexone Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-04-13 | Class II | Naltrexone Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, MFG: Mallinckrodt Inc., NDC 0406-1170 | Mckesson Medical-Surgical Inc. Corporate Office |
| 2018-10-05 | Class III | Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, | Orexigen Therapeutics, Inc. |
| 2018-08-09 | Class III | Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, D | Orexigen Therapeutics, Inc. |